Evolent Health (NYSE:EVH) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. This is a 120 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $652.520 million which beat the analyst consensus estimate of $597.997 million by 9.12 percent. This is a 46.86 percent increase over sales of $444.328 million the same period last year.